000060681 001__ 60681
000060681 005__ 20190709135454.0
000060681 0247_ $$2doi$$a10.1186/s12906-017-1638-y
000060681 0248_ $$2sideral$$a98230
000060681 037__ $$aART-2017-98230
000060681 041__ $$aeng
000060681 100__ $$aSanada, K.
000060681 245__ $$aEffects of mindfulness-based interventions on biomarkers in healthy and cancer populations: A systematic review
000060681 260__ $$c2017
000060681 5060_ $$aAccess copy available to the general public$$fUnrestricted
000060681 5203_ $$aBackground: Only a small number of articles have investigated the relationship between mindfulness-based interventions (MBIs) and biomarkers. The aim of this systematic review was to study the effect of MBIs on specific biomarkers (cytokines, neuropeptides and C-reactive protein (CRP)) in both healthy subjects and cancer patients. Methods: A search was conducted using PubMed, EMBASE, PsycINFO and the Cochrane library between 1980 and September 2016. Results: A total of 13 studies with 1110 participants were included. In the healthy population, MBIs had no effect on cytokines, but were found to increase the levels of the neuropeptide insulin-like growth factor 1 (IGF-1). With respect to neuropeptide Y, despite the absence of post-intervention differences, MBIs may enhance recovery from stress. With regard to CRP, MBIs could be effective in lower Body Mass Index (BMI) individuals. In cancer patients, MBIs seem to have some effect on cytokine levels, although it was not possible to determine which specific cytokines were affected. One possibility is that MBIs might aid recovery of the immune system, increasing the production of interleukin (IL)-4 and decreasing interferon gamma (IFN-¿). Conclusions: MBIs may be involved in changes from a depressive/carcinogenic profile to a more normalized one. However, given the complexity and different contexts of the immune system, and the fact that this investigation is still in its preliminary stage, additional randomized controlled trials are needed to further establish the impact of MBI programmes on biomarkers in both clinical and non-clinical populations.
000060681 536__ $$9info:eu-repo/grantAgreement/ES/FIS/PI13-01637$$9info:eu-repo/grantAgreement/ES/ISCIII/RD12-0005
000060681 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000060681 590__ $$a2.109$$b2017
000060681 591__ $$aINTEGRATIVE & COMPLEMENTARY MEDICINE$$b8 / 27 = 0.296$$c2017$$dQ2$$eT1
000060681 592__ $$a0.858$$b2017
000060681 593__ $$aComplementary and Alternative Medicine$$c2017$$dQ1
000060681 593__ $$aMedicine (miscellaneous)$$c2017$$dQ2
000060681 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000060681 700__ $$0(orcid)0000-0002-7931-4082$$aAlda Díez, M.$$uUniversidad de Zaragoza
000060681 700__ $$0(orcid)0000-0001-6261-3724$$aSalas Valero, M.
000060681 700__ $$aPérez-Yus, M.C.
000060681 700__ $$aDemarzo, M.M.P.
000060681 700__ $$0(orcid)0000-0001-5677-1662$$aMontero-Marín, J.
000060681 700__ $$aGarcía-Toro, M.
000060681 700__ $$0(orcid)0000-0002-3797-4218$$aGarcía-Campayo, J.$$uUniversidad de Zaragoza
000060681 7102_ $$11007$$2745$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Psiquiatría
000060681 773__ $$g17, 1 (2017), 125$$pBMC COMPLEMENTARY AND ALTERNATIVE MEDICINE$$tBMC COMPLEMENTARY AND ALTERNATIVE MEDICINE$$x1472-6882
000060681 8564_ $$s601887$$uhttps://zaguan.unizar.es/record/60681/files/texto_completo.pdf$$yVersión publicada
000060681 8564_ $$s102317$$uhttps://zaguan.unizar.es/record/60681/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000060681 909CO $$ooai:zaguan.unizar.es:60681$$particulos$$pdriver
000060681 951__ $$a2019-07-09-11:42:38
000060681 980__ $$aARTICLE